TITLE:
Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices

CONDITION:
Catheters, Indwelling

INTERVENTION:
Alfimeprase

SUMMARY:

      This trial is for patients with a central venous catheter (a vascular access device) that is
      not functioning properly (unable to withdraw blood). The trial compares a new blood clot
      dissolving agent (alfimeprase) against the currently used treatment.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Subjects must:

          -  have a dysfunctional Central Venous Access Device (CVAD) defined as unable to
             withdraw 3 mL blood

          -  have had the device in place for > 48 hours

          -  be clinically stable

          -  be 18 or older

          -  give informed consent
      
